OverviewChartProfileKey statisticsFinancialsTechnicalNewsTraderScreen

BioMerieux SA/  FR0013280286  /

Euronext - Paris
14/05/2024  17:36:30 Chg. -1.750 Volume Bid17:40:00 Ask17:40:00 Market Capitalization Dividend Y. P/E Ratio
95.250EUR -1.80% 214,218
Turnover: 20.38 mill.		 95.150Bid Size: 106 95.500Ask Size: 25 11.27 bill.EUR 0.89% 31.44
GlobeNewswire 29/04 OpGen Provides Update on Business Operations and Strategic Opportunities
GlobeNewswire 25/04 UIICore unveiling / ECCMID announcement Analyst Targets
GlobeNewswire 18/04 deepull appoints Kimberle Chapin, MD, as Chief Medical Officer and Wade Stevenson as Chief Marketing...
GlobeNewswire 04/12/2023 Oxford Biomedica signs agreement to acquire ABL Europe from Institut Mérieux, consolidating position...
GlobeNewswire 27/10/2023 USDA Appoints New Members to Food Safety Advisory Committee
GlobeNewswire 20/09/2023 Oxford Biomedica and Institut Mérieux enter into exclusive negotiations with respect to the proposed...
GlobeNewswire 19/10/2021 USDA Appoints New Members to Food Safety Advisory Committee
GlobeNewswire 05/10/2021 Quotient Limited Announces Appointment of Chief Commercial Officer
GlobeNewswire 04/10/2021 Quotient Limited Announces Appointment of New Chief Scientific & Medical Officer
GlobeNewswire 16/09/2021 Inventiva announces major recruitments to accelerate the development of lanifibranor in NASH
GlobeNewswire 01/06/2021 Quotient Limited Provides Fourth Quarter and Full Year Fiscal 2021 Results and provides Business Upd...
GlobeNewswire 10/03/2021 Oncorus Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Highlights
GlobeNewswire 23/02/2021 Quotient Limited Announces Manuel Mendez as Chief Executive Officer
GlobeNewswire 04/02/2021 Berkeley Lights Announces CFO Transition and C-Level Additions
GlobeNewswire 04/01/2021 Oncorus to Build GMP Viral Immunotherapy Clinical Manufacturing Facility in Andover, Mass.
GlobeNewswire 16/12/2020 MeMed Appoints Industry Veteran Chris Hibberd to its Board of Directors
GlobeNewswire 07/12/2020 Oncorus Appoints Steve Harbin as Chief Operating Officer and Chief of Staff
GlobeNewswire 29/09/2020 Synairgen plc - Interim results for the six months ended 30 June 2020
GlobeNewswire 17/09/2020 Victory Square Provides Corporate Update on the Strong Performance of Portfolio Companies
GlobeNewswire 15/07/2020 DNV3837 antibiotic candidate: the Phase II trial continues in the US
GlobeNewswire 15/06/2020 T2 Biosystems Announces Changes to Board of Directors
GlobeNewswire 04/05/2020 Alexis RIDEAU appointed Chief Executive Officer of DEINOVE with the ambition to strengthen the Comp...
GlobeNewswire 01/04/2020 Cancer Biomarker Sales to Reach US$ 27 Bn by 2025; Government Funding Pivotal in Accelerating Market...
GlobeNewswire 18/03/2020 Commercial launch of BIOME Oléoactif®, new cosmetic active co-developed by Deinove and Hallstar Fran...
GlobeNewswire 11/03/2020 DEINOVE passes the 2nd milestone of the AGIR program and receives €1.5m from Bpifrance